使用充电粒子放射治疗作为质瘤治疗方式后的生存结果:系统性审查和元分析
Bareq S Al-Lami1, Baqer S Al-Lami1, Yasir S Al-Lami1
1General Medicine, Hawler Medical University, Erbil, Iraq.
Journal of medical imaging and radiation sciences
|April 26, 2024
概括
与光子疗法相比,带电粒子疗法显示,质瘤患者的生存率有所改善. 建议进行进一步的研究来证实这些有前途的临床结果.
科学领域:
- 在瘤学瘤学.
- 辐射瘤学 辐射瘤学
- 医学物理 医学物理
背景情况:
- 充电粒子疗法是各种瘤的新兴治疗方法.
- 它对轴内脑瘤 (结质瘤) 的安全性和有效性需要进一步研究.
- 这项研究比较了带电粒子辐射和光子疗法之间的患者生存率.
研究的目的:
- 系统地审查和元分析用充电粒子疗法治疗质瘤患者的整体生存率与光子疗法.
- 为了评估这两种辐射方式的比较疗效.
主要方法:
- 在MEDLINE (PubMed),谷歌学者,Scopus和Cochrane数据库中进行了系统的文献搜索.
- 确定了相关的临床研究,并纳入了分析.
- 采用随机效应的元分析,将1,3年和5年的整体存活率估计结合起来.
主要成果:
- 包含1140名患者的19项研究被纳入了元分析.
- 与光子疗法相比,带电粒子辐射疗法在1年 (RR 1.17),3年 (RR 1.73) 和5年 (RR 2.00) 的总生存率显著更高.
- 患者的平均随访期为44.4个月.
结论:
- 与光子疗法相比,充电粒子疗法可能与质瘤患者的优异临床结果有关.
- 这些发现表明,充电粒子疗法在改善患者预后方面具有潜在的益处.
- 强烈建议进行更多前性随机试验,以验证这些结果并进一步探索预后因素.
相关概念视频
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K
Cancer Survival Analysis
863
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
863


